Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2003-8-4
pubmed:abstractText
Sixteen hospitals in Sweden, including those in urban and more sparsely populated areas, and the associated ambulance organizations were enrolled in a prospective evaluation of the feasibility of treating patients with a ST-elevation infarction with a thrombolytic agent (reteplase) before hospital admission. A physician staffed the ambulances in 1% of cases, a nurse in 67%, and a staff nurse in 32% of cases. In all, 64 patients in urban areas and 90 patients in rural areas were included. The occurrence of complications before hospital admission was low and similar in the 2 groups. The median interval between the onset of symptoms and the start of thrombolysis was 1 hour 44 minutes in urban areas versus 2 hours 14 minutes in rural areas (P = 0.03). The median arrival time (interval between onset of symptoms and arrival of the ambulance) tended to be shorter in urban areas (1 hr 10 min vs 1 hr 33 min; not significant) and the median interval between the arrival of the ambulance and the start of thrombolysis was shorter in urban areas (27 min vs 36 min; P < 0.0001). When comparing urban areas with the least-populated rural areas, differences in various delay times became even more marked. Patients in urban areas had a higher ejection fraction and fewer symptoms of heart failure after 30 days and a lower 1-year mortality.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0735-6757
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
263-70
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12898480-Aged, pubmed-meshheading:12898480-Electrocardiography, pubmed-meshheading:12898480-Emergency Medical Services, pubmed-meshheading:12898480-Female, pubmed-meshheading:12898480-Fibrinolytic Agents, pubmed-meshheading:12898480-Follow-Up Studies, pubmed-meshheading:12898480-Humans, pubmed-meshheading:12898480-Male, pubmed-meshheading:12898480-Myocardial Infarction, pubmed-meshheading:12898480-Prospective Studies, pubmed-meshheading:12898480-Recombinant Proteins, pubmed-meshheading:12898480-Rural Health, pubmed-meshheading:12898480-Safety, pubmed-meshheading:12898480-Sweden, pubmed-meshheading:12898480-Thrombolytic Therapy, pubmed-meshheading:12898480-Time Factors, pubmed-meshheading:12898480-Tissue Plasminogen Activator, pubmed-meshheading:12898480-Treatment Outcome, pubmed-meshheading:12898480-Urban Health
pubmed:year
2003
pubmed:articleTitle
Safety and delay time in prehospital thrombolysis of acute myocardial infarction in urban and rural areas in Sweden.
pubmed:affiliation
Division of Cardiology, South Hospital, SE-118 83 Stockholm, Sweden. leif.svensson@medklin.sos.sll.se
pubmed:publicationType
Journal Article, Comparative Study